op of the morning to you, and what a fine one it is. A warm and shiny sun is enveloping the Pharmalot campus this morning, where one of the short people has long since departed for the local schoolhouse and another short person is lingering for a holiday break. As for us, well, there is much to be done, which brings us to the list of tidbits below. All of which is to say the time has come for another cup of stimulation. Feel free to join us. And now, onward …

The Food and Drug Administration will add insulin to its campaign to increase competition, Bloomberg News explains. The FDA will add insulin products to a list of drugs that have lost their monopoly protections but that still lack a cheap generic version in order to highlight opportunities for generic makers. The agency has already indicated it will expedite review of any application for a product on the list.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.